Skip to content

SRRK

Scholar Rock Holding Corporation

NASDAQ · USHealthcareBiotechnology
$50.66-4.16%

Price as of Jul 20, 2026

SRRK capital

Scholar Rock Holding Corporation capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.75x
Net debt / equity
-0.81x
Debt / assets
0.38x
Debt / EBITDA
-0.51x
Net debt / EBITDA
0.56x

Liquidity & coverage

Current ratio
8.64x
Quick ratio
8.64x
Cash ratio
8.05x
Interest coverage
-55.53x
EBITDA / interest
-54.20x
Working capital
$455.6M

Cash & dividend

FCF / debt
-1.48x
Cash flow / debt
-1.48x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.